Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Liver metastases with unknown primary site].

V L Drug1, Ingrid Popa, Cristina Cijevschi

  • 1Institutul de Gastroenterologie şi Hepatologie, Facultatea de Medicină, Universitatea de Medicina si Farmacie Gr.T. Popa Iaşi.

Revista Medico-Chirurgicala a Societatii De Medici Si Naturalisti Din Iasi
|February 6, 2004
PubMed
Summary

Cancer of unknown primary site (CUP) affects 5-10% of patients. Liver biopsy is crucial for diagnosis and identifying treatable cancers, guiding therapy decisions for better patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hemorrhagic jejunal vascular malformations with loop telangiectasia in Turner's syndrome.

Clinics and research in hepatology and gastroenterology·2026
Same author

Isolated Hypoplastic left Rib Anomaly.

Irish medical journal·2023
Same author

Contrast-enhanced ultrasound for the assessment of focal nodular hyperplasia - results of a multicentre study.

Medical ultrasonography·2021
Same author

Effectiveness of 8- and 12-Week Treatment with Ombitasvir/ Paritaprevir/Ritonavir and Dasabuvir in Treatment-Naïve HCV Patients in a Real-Life Setting in Romania: the AMETHYST Study.

Journal of gastrointestinal and liver diseases : JGLD·2021
Same author

Geographic Distribution, Phenotype and Epidemiological Tendency in Inflammatory Bowel Disease Patients in Romania.

Medicina (Kaunas, Lithuania)·2019
Same author

Malnutrition Prevalence in Newly Diagnosed Patients with Inflammatory Bowel Disease - Data from the National Romanian Database.

Journal of gastrointestinal and liver diseases : JGLD·2019

Area of Science:

  • Oncology
  • Pathology
  • Medical Diagnostics

Context:

  • Cancer of unknown primary site (CUP) constitutes 5-10% of all cancer diagnoses.
  • The liver is a common metastatic site for various adenocarcinomas, accounting for 60% of CUP cases.
  • Accurate diagnosis is challenging, requiring comprehensive clinical evaluation and diagnostic procedures.

Purpose:

  • To highlight the diagnostic significance of liver biopsy in identifying primary tumors in CUP patients.
  • To determine which CUP patients may benefit from specific therapies based on histological findings.
  • To inform treatment strategies, distinguishing between potentially curable and palliative care approaches.

Summary:

  • Liver biopsy is essential for histological diagnosis in 5-10% of cancer patients with an unknown primary site.

Related Experiment Videos

  • It aids in identifying specific adenocarcinomas and other malignancies (e.g., breast, prostate, ovarian, lung) that respond to targeted therapies.
  • While systemic chemotherapy is common, its benefit is limited to patients with good performance status; best supportive care is often optimal.

    • Impact:

    • Facilitates personalized treatment selection for CUP patients, improving therapeutic efficacy.
    • Enables the identification of a subset of patients who can benefit from potentially curative or life-extending treatments.
    • Guides clinical decision-making towards the most appropriate care, whether targeted therapy or supportive measures, based on individual patient status.